{"url":"https://lda.senate.gov/api/v1/filings/a97988bf-e80b-4367-b70b-04f8d6c6f403/","filing_uuid":"a97988bf-e80b-4367-b70b-04f8d6c6f403","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2016,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/a97988bf-e80b-4367-b70b-04f8d6c6f403/print/","filing_document_content_type":"text/html","income":"10000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Donna F. Mullins, Managing Partner","dt_posted":"2016-10-20T13:01:45.733000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"409 7TH STREET, NW","registrant_address_2":"SUITE 450","registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20004","registrant":{"id":50796,"url":"https://lda.senate.gov/api/v1/registrants/50796/","house_registrant_id":34724,"name":"WINNING STRATEGIES WASHINGTON","description":"Government relations firm","address_1":"409 7TH STREET, NW","address_2":"SUITE 450","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20004","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CARL CHIDLOW","contact_telephone":"+1 202-589-0800","dt_updated":"2026-01-28T09:17:29.205119-05:00"},"client":{"id":157085,"url":"https://lda.senate.gov/api/v1/clients/157085/","client_id":1005698,"name":"TEAM JOSEPH","general_description":"Directing donated funding to support research in Duchenne Muscular Dystrophy","client_government_entity":false,"client_self_select":null,"state":"MI","state_display":"Michigan","country":"US","country_display":"United States of America","ppb_state":"MI","ppb_state_display":"Michigan","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-01-15"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Implementation of the accelerated approval provision of FDASIA as it pertains to treatments applicable for rare, deadly childhood diseases","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23160,"prefix":null,"prefix_display":null,"first_name":"DONNA","nickname":null,"middle_name":null,"last_name":"MULLINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59796,"prefix":null,"prefix_display":null,"first_name":"CHELSEY","nickname":null,"middle_name":null,"last_name":"PENROD HICKMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Implementation of the accelerated approval provision of FDASIA as it pertains to treatments applicable for rare, deadly childhood diseases","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23160,"prefix":null,"prefix_display":null,"first_name":"DONNA","nickname":null,"middle_name":null,"last_name":"MULLINS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":59796,"prefix":null,"prefix_display":null,"first_name":"CHELSEY","nickname":null,"middle_name":null,"last_name":"PENROD HICKMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}